Skip to main content
. 2020 Jan 8;63(4):788–798. doi: 10.1007/s00125-019-05081-8

Fig. 2.

Fig. 2

 Contribution of biomarker sets to prediction of final eGFR (a, b) or final eGFR <30 (c, d) when starting from a model containing basic covariates (age, sex, diabetes duration, study day eGFR and length of follow-up). Variable selection was based on: serum biomarkers (a, c); and serum biomarkers and ACR (b, d). A1Micro, α-1-microglobulin; CLU, clusterin; Cys-C, cystatin C; MMP8, matrix metalloproteinase-8; SDC1, syndecan 1